Monday, August 4, 2025

Latest

Tilray Sees Gotham Green Look To Sell Recently Acquired Shares

It appears that Gotham Green Partners has approximately zero interest in being a shareholder of Tilray Inc (TSX: TLRY) (NASDAQ: TLRY). On Friday, the issuer filed an 8-K indicating that the fund was already looking to sell its stake in the company that it just recently obtained.

In total, Gotham Green and its affiliates are looking to sell up to 9.8 million shares of Tilray, as per a secondary offering filed on Friday. A total of 8.4 million common shares are held directly by Gotham Green, while a further 1.1 million are held by Pura Vida, and 0.3 million are held by Parallax.

The shares being sold are believe to have just recently been obtained, in connection with Tilray’s purchase of certain outstanding convertible notes in Medmen Enterprises (CSE: MMEN).

With a proposed maximum offering price of $12.68, the offering is expected to provide up to $124.5 million in gross proceeds from the selling shareholders, from which Tilray will see nothing.

A timeline for the transaction was not provided, with the prospectus also acting as a registration statement for the shares.

Tilray last traded at $15.45 on the TSX.


Information for this briefing was found via Edgar and Tilray. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

San Dimas: First Majestic Silver’s Sleeper Asset

New Gold Q2 Earnings: Record Free Cash Flow

STLLR Gold: The Tower Gold PEA

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Cannabis Executives Complain Over Lack of Tax Reform in Canadian Budget… While Making Bank

Top executives from leading cannabis companies in Canada have voiced their dissatisfaction with the absence...

Thursday, April 18, 2024, 11:17:16 AM

Medmen: Canaccord Drops Price Target To $0.35 After Q1 Results

On November 9th, Medmen Enterprises (CSE: MMEN) reported their fiscal first-quarter financial results. The company...

Sunday, November 14, 2021, 10:03:00 AM

Medmen Terminates PharmaCann Merger

Medmen Enterprises (CSE: MMEN) announced this morning that it will be terminating its merger agreement...

Tuesday, October 8, 2019, 08:59:05 AM

Hexo Corp Defaults On Secured Convertible Debt, Lender Waives Event Due To Tilray Deal

The inevitable has finally happened. Hexo Corp (TSX: HEXO) this morning formally indicated that it...

Monday, March 14, 2022, 07:38:46 AM

Tilray To Acquire 8 Anheuser-Busch Beverage Brands For $85 Million

Tilray Brands (NASDAQ: TLRY) has revealed its engagement in a definitive agreement to acquire eight...

Tuesday, August 8, 2023, 09:21:24 AM